InVivo Therapeutics Holdings Corporation
USD0.32
-0.17 (-34.28%)
CEO
Richard M. Toselli
IPO Date
2010-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.41
Prev. Close
$0.49
Day Low
$0.30
Day High
$0.41
52W Low
$0.22
52W High
$2.40
Market Cap
$0.00B
Volume
1.61M
| 4,200 |
| $0.00 |
| 21 Nov 2022 | CHRISTOPHER RICHARD | Chief Financial Officer | A-Award | Acquired | 20,800 | $0.00 |
| 21 Nov 2022 | MERRIFIELD C ANN | director | A-Award | Acquired | 4,200 | $0.00 |
| 21 Nov 2022 | Toselli Richard M. | CEO and CMO | A-Award | Acquired | 61,000 | $0.00 |
| 21 Nov 2022 | Morrison Christina | director | A-Award | Acquired | 4,200 | $0.00 |
| 21 Nov 2022 | ROSENTHAL BOB | director | A-Award | Acquired | 4,200 | $0.00 |
| 23 Dec 2021 | Toselli Richard M. | director, officer: See Remarks | F-InKind | Disposed | 16 | $0.54 |
| 23 Jun 2021 | Toselli Richard M. | director, officer: See Remarks | F-InKind | Disposed | 21 | $0.74 |
| 22 Mar 2021 | ROBERTS RICHARD JOHN | director | A-Award | Acquired | 15,000 | $1.10 |